This web site is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.


AstraZeneca PLC

Drug Names(s): fulvestrant

Description: Faslodex (Fulvestrant) is an estrogenreceptor antagonist that binds to the estrogen receptor in a competitivemanner with affinity comparable to that of estradiol. Fulvestrantdownregulates the ER protein in human breast cancer cells.

Faslodex News

Additional information available to subscribers only:

  • Targets
  • Routes
  • Catalysts
  • Designations
  • Events

Request a Free Demo Subscriber Login Search for another drug